Oleogel-S10
Sponsors
Birken AG, Amryt Research Limited, Memorial Sloan Kettering Cancer Center, Chiesi Farmaceutici S.p.A.
Conditions
Accelerating the Epithelialization of Split Thickness Skin GraftBreast CancerBreast Cancer StageBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer Stage IVCollagen Diseases
Phase 2
Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)
CompletedNCT01294241
Start: 2010-11-30End: 2011-06-30Updated: 2018-01-23
Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites
CompletedNCT01294254
Start: 2010-04-30End: 2010-11-30Updated: 2015-04-03
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
CompletedNCT05190770
Start: 2021-12-15End: 2024-08-27Updated: 2025-12-03
Phase 3
Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa
CompletedNCT03068780
Start: 2017-03-29End: 2022-05-27Updated: 2023-07-20
A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa
RecruitingNCT06917690
Start: 2025-04-18End: 2029-09-30Target: 6Updated: 2025-12-22